The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B

Table 2

Clinical characteristics of the CHB nonsignificant liver fibrosis group (S0-1) and significant liver fibrosis (S2-4) cases ().

Clinical characteristics	S0-1	S2-4
Male/female	16/9	21/12	1.0
Age (years old)			0.064
Blood cell counts (10^9/L)			0.118
Hemoglobin (g/L)			0.224
Blood platelet (10^9/L)			0.04
ALT (U/L)			0.107
AST (U/L)			0.109
γ-GT (U/L)			0.123
ALP (U/L)			0.09
T-Bil (μmol/L)			0.761
D-Bil (μmol/L)			0.807
TP (g/L)			0.148
ALB (g/L)			0.291
TC (U/L)			0.889
TG (U/L)			0.065
AFP			0.08
INR			0.233
HBV-DNA (10^7 U/L)			0.743
HBeAg-positive rate (%)	60%	72%	0.399